Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies

Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies

Alzheimer’s disease (AD) is the most common neurodegenerative disorder, accounting for approximately 70% of dementia cases worldwide. Patients gradually exhibit cognitive decline, such as memory loss, aphasia, and changes in personality and behavior. Research has shown that mitochondrial dysfunction...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuguang Wang, Zuning Liao, Qiying Zhang, Xinyuan Han, Changqing Liu, Jin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
mitochondria
AD
dysfunction
mechanisms
therapeutic targets
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1484373/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items